Hikal Ltd is Rated Strong Sell

Current Rating and Its Significance

MarketsMOJO’s Strong Sell rating for Hikal Ltd indicates a cautious stance for investors, signalling that the stock currently exhibits multiple risk factors that outweigh potential rewards. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. While the rating was assigned on 14 Nov 2025, it remains relevant today given the persistent challenges reflected in the company’s recent performance and outlook.

Quality Assessment: Below Average Fundamentals

As of 27 January 2026, Hikal Ltd’s quality grade is assessed as below average. The company has demonstrated weak long-term fundamental strength, with a compounded annual growth rate (CAGR) of operating profits declining by 16.24% over the past five years. This negative growth trend highlights operational challenges and diminishing profitability. Additionally, the company’s ability to service debt is limited, evidenced by a high Debt to EBITDA ratio of 2.51 times, which raises concerns about financial leverage and solvency risks.

Return on Equity (ROE), a key measure of profitability relative to shareholders’ funds, averages only 8.00%, signalling low efficiency in generating returns for investors. This below-par profitability further supports the cautious rating, as it suggests limited capacity for value creation in the near term.

Valuation: Attractive but Risk-Weighted

Despite the weak fundamentals, Hikal Ltd’s valuation grade is currently attractive. This suggests that the stock price may be trading at a discount relative to its intrinsic value or sector peers. However, the attractive valuation is tempered by the company’s deteriorating financial health and negative earnings trends, which imply that the low price may reflect underlying risks rather than a bargain opportunity.

Financial Trend: Very Negative Performance

The financial trend for Hikal Ltd is very negative as of 27 January 2026. The company reported a sharp fall in earnings per share (EPS), declining by 320.54% in the most recent quarter. This dramatic drop is accompanied by two consecutive quarters of negative results, underscoring ongoing operational difficulties.

Quarterly net sales have fallen by 30.5% to ₹318.50 crores compared to the previous four-quarter average, while the quarterly profit after tax (PAT) plunged to a loss of ₹34.90 crores. Return on Capital Employed (ROCE) for the half-year stands at a low 4.44%, indicating poor utilisation of capital resources. These metrics collectively paint a picture of a company struggling to maintain profitability and growth momentum.

Technical Outlook: Bearish Momentum

From a technical perspective, Hikal Ltd’s stock exhibits a bearish trend. The stock has delivered negative returns across multiple time frames, including a 41.87% decline over the past year and a 41.95% drop over the last six months. Shorter-term performance is also weak, with losses of 17.10% over one month and 6.71% over one week. This sustained downward momentum reflects investor sentiment and market pressures, reinforcing the Strong Sell rating.

Comparative Performance and Market Context

Hikal Ltd’s underperformance is notable when compared to broader market indices such as the BSE500. The stock has lagged behind the benchmark over the last three years, one year, and three months, indicating persistent challenges relative to its peers. This relative weakness further justifies the cautious stance for investors considering exposure to this smallcap pharmaceutical and biotechnology company.

Implications for Investors

For investors, the Strong Sell rating suggests that Hikal Ltd currently carries significant risks that may outweigh potential rewards. The combination of weak fundamentals, negative financial trends, and bearish technical signals indicates that the stock is not favourably positioned for near-term recovery. While the valuation appears attractive, it is important to recognise that this may reflect market concerns about the company’s operational and financial health rather than a genuine buying opportunity.

Investors should carefully consider these factors and monitor any developments that could improve the company’s outlook before initiating or increasing positions. Diversification and risk management remain key when dealing with stocks exhibiting such profiles.

Summary of Key Metrics as of 27 January 2026

Hikal Ltd’s Mojo Score currently stands at 12.0, reflecting the Strong Sell grade, down from a previous score of 34 (Sell) as of 14 Nov 2025. The stock’s recent price movement shows a marginal decline of 0.05% on the day, continuing a broader downtrend. The company’s financial dashboard highlights a negative operating profit CAGR of -16.24% over five years, a high Debt to EBITDA ratio of 2.51 times, and a low average ROE of 8.00%.

Quarterly results reveal a 30.5% drop in net sales and a 320.54% fall in EPS, with PAT turning negative at ₹-34.90 crores. The ROCE for the half-year is at a low 4.44%, underscoring inefficient capital utilisation. Stock returns over various periods remain deeply negative, with a 41.87% loss over one year and a 41.95% decline over six months.

Looking Ahead

Given the current financial and technical outlook, Hikal Ltd’s Strong Sell rating advises investors to exercise caution. The company faces significant headwinds that have yet to be resolved, and the stock’s valuation, while attractive, is reflective of these risks. Investors should closely monitor quarterly results and any strategic initiatives that may improve profitability and operational efficiency before reconsidering their stance.

In summary, the Strong Sell rating from MarketsMOJO, last updated on 14 Nov 2025, remains pertinent as of 27 January 2026, based on the company’s ongoing challenges across quality, valuation, financial trend, and technical parameters.

Unlock special upgrade rates for a limited period. Start Saving Now →